Prostate cancer decisions — 2022

The Veteran's prostate cancer is presumed service connected due to herbicide exposure in Thailand.

The Board has remanded the case due to outstanding VA treatment records and a need for a VA medical opinion on the combined effects of service-connected disabilities.

The Board has granted service connection for prostate cancer, finding that the Veteran's exposure to herbicides at Udorn RTAFB in Thailand during his active duty qualifies him for presumptive service connection.

The Veteran's service-connected disabilities, including prostate cancer, tinnitus, and chronic diarrhea, do not render him unable to secure or follow substantially gainful employment. The Board finds that the criteria for a TDIU prior to September 23, 2019 are not met.

The Board found that the reduction of the Veteran's prostate cancer rating from 100% to 0% was proper, as there were no local reoccurrences or metastasis and no residuals.

The Board denied service connection for prostate cancer, finding that the Veteran's condition is not related to his active service or exposure at Camp Lejeune.

The Veteran requested to withdraw his appeal regarding the effective date for prostate cancer service connection, and the Board has dismissed the case as a result.

The Board has granted service connection for ischemic heart disease, AL amyloidosis, and multiple myeloma as a result of the Veteran's exposure to herbicide agents during his active duty in Thailand. Service connection is denied for lung cancer and prostate cancer.

The Veteran's service-connected disabilities alone do not render him unable to obtain or maintain substantially gainful employment prior to December 16, 2020.

The Veteran's claim for service connection for a skin disorder, hypertension, and prostate cancer was granted. The rating for prostate cancer was reduced from 100% to 60%, effective May 1, 2017.

The Veteran's TDIU claim is granted, and his erectile dysfunction rating is remanded for further examination.

The Board has decided to remand the case due to a lack of a VA medical opinion regarding whether the Veteran's prostate cancer was caused by contaminated water exposure at Camp LeJeune during his service.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that it is not related to his active duty service or exposure to contaminated drinking water at Camp Lejeune. The Board also found that there was no secondary service connection due to hairy cell leukemia.

The Board has remanded the Veteran's claims for prostate cancer residuals and SMC due to a lack of explanation in the September 2019 decision regarding his use of absorbent materials. A new VA examination is needed, and the AOJ must issue a Supplemental Statement of the Case (SSOC).

The Veteran's appeal includes claims for an initial rating greater than 20 percent for bilateral hearing loss and entitlement to TDIU, which are both remanded.,Service connection for back pain is denied.

The Board denied service connection for prostate cancer, finding that the Veteran's current condition is not related to his in-service exposure to ionizing radiation.

The Veteran's appeals for increased disability ratings and SMC have been dismissed as he has withdrawn his appeal.

The Board denied service connection for prostate cancer and diabetes, finding that there was no evidence of in-service exposure to herbicides or other conditions that would support presumptive service connection. The Veteran's current disabilities did not manifest within the applicable prescriptive periods.

The Board has remanded the Veteran's claims for service connection due to exposure to tactical herbicide agents, as well as asbestos exposure. The issues include heart disability, hypertension, prostate cancer, skin disability, bilateral upper and lower extremity peripheral neuropathy, and respiratory disability.

The Veteran's cervical disorder, prostate cancer, and erectile dysfunction are all granted service connection as secondary to his pre-existing conditions.,Special monthly compensation for loss of use of a creative organ is also granted.